Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience gross margin
Gross margin is gross profit as a percentage of revenue.
Harvard Bioscience's gross margin for the twelve months ending Jun 30, 2026 was 58.2%. For fiscal 2025 it was 57.7%, against 58.2% the year before. The highest annual figure on record is 58.9% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.7% | −0.5 |
| FY2024 | Dec 31, 2024 | 58.2% | −0.7 |
| FY2023 | Dec 31, 2023 | 58.9% | +5.2 |
| FY2022 | Dec 31, 2022 | 53.7% | −3.2 |
| FY2021 | Dec 31, 2021 | 56.9% | +0.0 |
| FY2020 | Dec 31, 2020 | 56.8% | +1.5 |
| FY2019 | Dec 31, 2019 | 55.4% | +3.1 |
| FY2018 | Dec 31, 2018 | 52.3% | +1.7 |
| FY2017 | Dec 31, 2017 | 50.6% | +4.3 |
| FY2016 | Dec 31, 2016 | 46.3% | +1.5 |
| FY2015 | Dec 31, 2015 | 44.8% | −0.6 |
| FY2014 | Dec 31, 2014 | 45.4% | +0.1 |
| FY2013 | Dec 31, 2013 | 45.4% | −1.7 |
| FY2012 | Dec 31, 2012 | 47.1% | +1.0 |
| FY2011 | Dec 31, 2011 | 46.1% | −1.8 |
| FY2010 | Dec 31, 2010 | 47.9% | −0.7 |
| FY2009 | Dec 31, 2009 | 48.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 55.6% | −0.8 |
| Q1 FY2026 | Mar 31, 2026 | 59.0% | +3.0 |
| Q4 FY2025 | Dec 31, 2025 | 59.7% | +2.7 |
| Q3 FY2025 | Sep 30, 2025 | 58.4% | +0.3 |
| Q2 FY2025 | Jun 30, 2025 | 56.4% | −0.8 |
| Q1 FY2025 | Mar 31, 2025 | 56.0% | −4.3 |
| Q4 FY2024 | Dec 31, 2024 | 57.1% | −0.9 |
| Q3 FY2024 | Sep 30, 2024 | 58.1% | +0.0 |
| Q2 FY2024 | Jun 30, 2024 | 57.2% | −0.7 |
| Q1 FY2024 | Mar 31, 2024 | 60.3% | −0.9 |
| Q4 FY2023 | Dec 31, 2023 | 58.0% | +2.3 |
| Q3 FY2023 | Sep 30, 2023 | 58.1% | +12.9 |
| Q2 FY2023 | Jun 30, 2023 | 58.0% | +1.0 |
| Q1 FY2023 | Mar 31, 2023 | 61.2% | +5.0 |
| Q4 FY2022 | Dec 31, 2022 | 55.7% | −3.5 |
| Q3 FY2022 | Sep 30, 2022 | 45.2% | −9.8 |
| Q2 FY2022 | Jun 30, 2022 | 57.0% | +1.0 |
| Q1 FY2022 | Mar 31, 2022 | 56.2% | −1.0 |
| Q4 FY2021 | Dec 31, 2021 | 59.2% | +2.0 |
| Q3 FY2021 | Sep 30, 2021 | 55.0% | −1.2 |
| Q2 FY2021 | Jun 30, 2021 | 56.0% | −3.4 |
| Q1 FY2021 | Mar 31, 2021 | 57.2% | +2.6 |
| Q4 FY2020 | Dec 31, 2020 | 57.2% | +1.5 |
| Q3 FY2020 | Sep 30, 2020 | 56.1% | +1.5 |
| Q2 FY2020 | Jun 30, 2020 | 59.4% | +5.5 |
| Q1 FY2020 | Mar 31, 2020 | 54.6% | −2.7 |
| Q4 FY2019 | Dec 31, 2019 | 55.6% | +0.3 |
| Q3 FY2019 | Sep 30, 2019 | 54.6% | −0.6 |
| Q2 FY2019 | Jun 30, 2019 | 53.9% | +5.2 |
| Q1 FY2019 | Mar 31, 2019 | 57.3% | +7.7 |
| Q4 FY2018 | Dec 31, 2018 | 55.3% | +4.4 |
| Q3 FY2018 | Sep 30, 2018 | 55.2% | +4.5 |
| Q2 FY2018 | Jun 30, 2018 | 48.7% | +0.9 |
| Q1 FY2018 | Mar 31, 2018 | 49.6% | −3.4 |
| Q4 FY2017 | Dec 31, 2017 | 50.9% | +5.1 |
| Q3 FY2017 | Sep 30, 2017 | 50.8% | +4.0 |
| Q2 FY2017 | Jun 30, 2017 | 47.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 53.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 45.8% | – |
| Q3 FY2016 | Sep 30, 2016 | 46.7% | – |
See a number that looks wrong?